Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 18/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 13/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 13/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 12/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4619666 | 1.00 | ADORA2A (0.43) | ADORA2AADORA3ADORA1ADORA2BCA12 | |
| SCHEMBL2806229 | 1.00 | ADORA2A (0.43) | ADORA2AADORA3ADORA1ADORA2BCA12 | |
| SCHEMBL11968517 | 0.96 | ADORA2A (0.46) | ADORA2AADORA3ADORA1ADORA2BCA12 | |
| SCHEMBL2806275 | 0.96 | ADORA2A (0.46) | ADORA2AADORA3ADORA1ADORA2BCA12 | |
| SCHEMBL2806273 | 0.96 | ADORA2A (0.46) | ADORA2AADORA3ADORA1ADORA2BCA12 | |
| SCHEMBL2806278 | 0.96 | ADORA2A (0.46) | ADORA2AADORA3ADORA1ADORA2BCA12 | |
| SCHEMBL2807653 | 0.95 | ADORA2A (0.45) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL12049803 | 0.95 | ADORA2A (0.45) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL2807659 | 0.95 | ADORA2A (0.45) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL2807657 | 0.95 | ADORA2A (0.45) | ADORA2AADORA3ADORA1ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2044070-B1 | PURINE DERIVATIVES AS A2A AGONISTS | NOVARTIS AG (CH) | 2012-08-22 | — | — | EP | claimed |
| EP-2044070-B1 | PURINE DERIVATIVES AS A2A AGONISTS | NOVARTIS AG (CH) | 2012-08-22 | — | — | EP | disclosed |
| EP-1889846-A1 | Purine derivatives as A2a agonists | Novartis AG (CH) | 2008-02-20 | — | — | EP | disclosed |